Thomas Smith

Mr. Thomas J.
Smith is a Senior Managing Director of Immunology & Metabolism at Leerink Partners LLC.
He is also a Senior Research Analyst covering Immunology and Metabolism.
Prior to covering the Immunology and Metabolism sector, Mr. Smith was a key member of Leerink Partners’ Targeted Oncology team helping to deliver in-depth fundamental research to clients.
Prior to joining the firm in 2018, he was most recently a Vice President and Research Analyst at Morgan Stanley, covering leading and emerging biopharmaceutical companies across numerous therapeutic areas, including oncology, NASH, and lead coverage of women’s health companies.
Prior to that, he worked at FBR Capital Markets on the biotechnology team, responsible for coverage of large, mid-, and small cap companies.
Mr. Smith began his career at Bloomberg where he held roles of increasing responsibility, including coverage of the biotech and specialty pharmaceutical sectors for Bloomberg Intelligence.
He earned his B.S.
in Finance and Psychology from The College of New Jersey.